Literature DB >> 17293170

Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.

Nicola J Veitch1, Margaret Ennis, John P McAbney, Peggy F Shelbourne, Darren G Monckton.   

Abstract

Huntington disease (HD) is associated with an unstable trinucleotide CAG.CTG repeat expansion. Although the repeat length is inversely correlated with the age-at-onset of symptoms, variability between patients who have inherited the same HD repeat length clearly suggests that other factors influence this aspect of the disease. As repeat length profiles in somatic tissues suggest that repeat length gains may contribute to both the tissue-specificity and progressive nature of HD pathogenesis, genetic modifiers of mutation length variability may therefore influence the age-at-onset of the disease. Using a sensitive single molecule-PCR assay we show that HD mutation length profiles in buccal cell DNA vary from individual to individual. The resulting data provide the first quantitative evidence that inherited CAG.CTG repeat length has a major influence on somatic CAG.CTG repeat length variation. In addition, we confirm that further environmental and/or genetic modifiers of repeat length variation exist and discuss the implications that our results may have on understanding the factors that influence severity and age-at-onset of Huntington disease symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17293170     DOI: 10.1016/j.dnarep.2007.01.002

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  23 in total

Review 1.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 2.  Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models.

Authors:  Vanessa C Wheeler; Vincent Dion
Journal:  J Huntingtons Dis       Date:  2021

Review 3.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

4.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

5.  DNA instability in replicating Huntington's disease lymphoblasts.

Authors:  Milena Cannella; Vittorio Maglione; Tiziana Martino; Giuseppe Ragona; Luigi Frati; Guo-Min Li; Ferdinando Squitieri
Journal:  BMC Med Genet       Date:  2009-02-11       Impact factor: 2.103

6.  Factors associated with HD CAG repeat instability in Huntington disease.

Authors:  V C Wheeler; F Persichetti; S M McNeil; J S Mysore; S S Mysore; M E MacDonald; R H Myers; J F Gusella; N S Wexler
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

7.  Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.

Authors:  Ella Dragileva; Audrey Hendricks; Allison Teed; Tammy Gillis; Edith T Lopez; Errol C Friedberg; Raju Kucherlapati; Winfried Edelmann; Kathryn L Lunetta; Marcy E MacDonald; Vanessa C Wheeler
Journal:  Neurobiol Dis       Date:  2008-09-30       Impact factor: 5.996

Review 8.  A brief history of triplet repeat diseases.

Authors:  Helen Budworth; Cynthia T McMurray
Journal:  Methods Mol Biol       Date:  2013

9.  Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.

Authors:  Meera Swami; Audrey E Hendricks; Tammy Gillis; Tiffany Massood; Jayalakshmi Mysore; Richard H Myers; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2009-05-23       Impact factor: 6.150

10.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.